Israel Englander Avenue Therapeutics, Inc. Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.22 - $0.56 $83 - $213	-381 Reduced 3.28%	11,247 $3,000
Q1 2022 May 16, 2022	SELL	$0.22 - $0.96 $12,782 - $55,778	-58,103 Reduced 83.32%	11,628 $6,000
Q4 2021 Feb 14, 2022	BUY	$0.88 - $1.78 $3,382 - $6,842	3,844 Added 5.83%	69,731 $63,000
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.65 $10,362 - $18,555	-7,002 Reduced 9.61%	65,887 $98,000
Q2 2021 Aug 16, 2021	BUY	$2.41 - $7.11 $175,662 - $518,240	72,889 New	72,889 $183,000
Q2 2020 Aug 14, 2020	SELL	$8.29 - $11.47 $585,298 - $809,816	-70,603 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$6.44 - $11.32 $454,683 - $799,225	70,603 New	70,603 $631,000
Q4 2017 Feb 14, 2018	SELL	$3.53 - $5.64 $164,858 - $263,399	-46,702 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.08 - $6.68 $237,246 - $311,969	46,702	46,702 $258,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.